- authorisedTherapeutic use (Phase IV)
A Multicenter Randomized Controlled Trial Assessing the Efficacy and Safety of Recombinant Human Follicle Stimulating Hormone (r-hFSH-alfa originator) and Human Chorionic Gonadotropin (hCG) in Enhancing Sperm Concentration in Men with Oligozoospermia, Low Testosterone, and Normal FSH Serum Levels (APHRODITE Group 3): A Collaborative Research Initiative
This study looks at new ways to help men with fertility problems. It tests if certain hormone treatments can increase sperm count in men who have low sperm and low testosterone, but normal levels of another hormone called FSH. The main aim is to see how these treatments affect sperm concentration.
Italy · Spain · Germany - ongoing, recruitingTherapeutic exploratory (Phase II)
NAPO - Novel Approach for Oligospermia
This study, called NAPO, is looking into how a new medicine called Prolia might help men with male infertility, specifically those with a low sperm count. Researchers will compare Prolia to a dummy treatment to see if it improves sperm concentration.
Denmark - authorisedTherapeutic exploratory (Phase II)
The NOVA-NOA Trial A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoospermia
This study, called NOVA-NOA, is looking into a new medicine called Leflutrozole to treat male infertility when sperm aren't found in a man's ejaculate. We want to see if this medicine can help men produce sperm in their semen.
Denmark - ongoing, recruitingTherapeutic exploratory (Phase II)
NT-NOA - Novel Treatment of some men with Non-Obstructive Azoospermia Et klinisk interventionsforsøg
This study looks at new treatments for men with a specific type of male infertility where no sperm are found when ejaculating. It aims to see if certain new medicines can help these men produce sperm that could lead to a pregnancy, improving their chances of having a family.
Denmark